+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years +
MALE
ID03246802

High Dose Rate Partial Prostate Brachytherapy for Treating Local Recurrence of Prostate Cancer After Previous Radiation

Led by British Columbia Cancer Agency · Updated on 2026-06-29

30

Participants Needed

1

Research Sites

261 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of high dose rate HDR partial prostate brachytherapy as a treatment for men with recurrent prostate cancer after initial external beam radiotherapy. The study focuses on men whose cancer has returned locally and who are suitable for this salvage therapy. Advanced imaging with multiparametric MRI mpMRI helps identify the exact site of recurrence, allowing targeted treatment. This study aims to evaluate the safety and effectiveness of HDR brachytherapy in this setting, where local recurrence rates after initial treatment can be high. Participants will receive two fractions of HDR brachytherapy delivered to the identified recurrent tumor site within the prostate. Treatment planning involves mpMRI combined with transrectal ultrasound to define the target area plus a margin for safety. The two treatments are given two weeks apart from a single implant. After treatment, patients will be monitored for side effects, quality of life, and prostate cancer activity using questionnaires and blood tests. During the study, participants will be regularly assessed for treatment-related toxicity and urinary symptoms using standardized questionnaires such as the Expanded Prostate Cancer Index and the International Prostate Symptom Score. Prostate Specific Antigen PSA levels will be monitored to evaluate disease control, and if PSA rises, additional imaging with PSMA PET may be performed. The primary outcome measures include monitoring for late severe gastrointestinal or urinary side effects over 3 to 60 months. Overall participation may last several years to assess long-term safety and effectiveness.

CONDITIONS

Brief Title

Partial Prostate Salvage High Dose Rate Brachytherapy

Research Team

J

Juanita Crook, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here